HomeXBIT • NASDAQ
XBiotech Inc
add
$2.75
1.10%
After Hours:(1.82%)+0.050
$2.80
Closed: Sep 22, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.34M | -57.66% |
Net income | -1.76M | 86.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.90M | 59.42% |
Effective tax rate | -1.62% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.94M | -18.88% |
Total assets | 178.68M | -17.11% |
Total liabilities | 5.62M | -70.20% |
Total equity | 173.06M | — |
Shares outstanding | 30.49M | — |
Price to book | 0.48 | — |
Return on assets | -8.79% | — |
Return on capital | -9.11% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.76M | 86.50% |
Cash from operations | -5.99M | 47.35% |
Cash from investing | -51.00K | 91.87% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.96M | 76.35% |
Free cash flow | -5.18M | 43.27% |
Previous close
$2.72
Day range
$2.63 - $2.75
Year range
$2.50 - $8.32
Market cap
83.84M USD
Avg Volume
52.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Founded
2005
Headquarters
Website
Employees
92
